P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)

Specht, HM; Pelzel, J; Hautmann, H; Huber, RM; Schossow, B; Molls, M; Multhoff, G

doi:10.1186/2051-1426-2-S2-P41

Article metrics
Last updated: Fri, 19 Apr 2024 4:27:19 Z

P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)

Access & Citations

1171

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.